Youngjin Ha

  • Partner
  • T. +82-2-3404-0959
  • F. +82-2-3404-7305
  • E. youngjin.ha@bkl.co.kr

Overview

Youngjin Ha is a partner of Bae, Kim & Lee LLC, and her practice focuses on all the matters involving securities and finance such as capital market, corporate finance, acquisition finance, financial regulation, securitization, structured finance, and project finance.

Ms. Ha also represented and advised clients on securities offering, KRX IPO of domestic and international companies, private equity investment, foreign investment, acquisition finance and project financing accompanying major M&As and projects, and financial dispute matters.

Ms. Ha graduated with top honors from Korea University Law School in 2012 and was admitted to the Korean Bar in the same year. After joining BKL, she earned an LL.M. from Harvard Law School and was admitted to the New York Bar in the same year.

Representative Experience

2019-2020 Visiting Attorney, Greenberg Traurig LLP, Seoul
2012-Present Bae, Kim & Lee LLC
See More
2022-Present Member, Small Enterprise Credit Risk Management Committee, Korea Federation of Small and Medium Business
2022-2023 Adjunct Professor, Korea University School of Law

Representative Matters

KRX IPOs by domestic/foreign companies (Kakao Bank, Krafton, Hyundai Heavy Industries, Kakao Games, Samsung Biologics, Doosan Bobcat, Celltrion Healthcare, Englewood Lab, Access Bio. Inc., Organic Tea Cosmetics, GRT, etc.)
Debt issuance transactions of Korean government, domestic/foreign companies and public institutions
Advised private equity funds on their acquisition financing accompanied in M&A transactions (i.e., Affinity Equity Partners on its acquisition of LocknLock, Shinhan Financial Group and recapitalization of SSG.com investment, Credit Suisse as lender for Carlyle's share acquisition of KB Financial Group, Carlyle Group on its acquisition of Twosome Place etc.)
Advised Kakao Corp. and Hanwha Chemical on the issuance of GDR and listing on the Singapore Exchange
Advised on cross-border and overseas alternative investment transaction (Portfolio investment in LA logistics center, mezzanine loan investment in U.S. hotel, etc.)
KRX IPOs by domestic/foreign companies (Kakao Bank, Krafton, Hyundai Heavy Industries, Kakao Games, Samsung Biologics, Doosan Bobcat, Celltrion Healthcare, Englewood Lab, Access Bio. Inc., Organic Tea Cosmetics, GRT, etc.)
Debt issuance transactions of Korean government, domestic/foreign companies and public institutions
Advised private equity funds on their acquisition financing accompanied in M&A transactions (i.e., Affinity Equity Partners on its acquisition of LocknLock, Shinhan Financial Group and recapitalization of SSG.com investment, Credit Suisse as lender for Carlyle's share acquisition of KB Financial Group, Carlyle Group on its acquisition of Twosome Place etc.)
Advised Kakao Corp. and Hanwha Chemical on the issuance of GDR and listing on the Singapore Exchange
Advised on cross-border and overseas alternative investment transaction (Portfolio investment in LA logistics center, mezzanine loan investment in U.S. hotel, etc.)
Advised on financial dispute matters relating to investments involving private funds, derivative-linked securities, specific fund trust and others
Advised various clients on NPL transaction, asset securitization, project financing and other structured financing matters

Education

2019 Harvard Law School (LL.M.)
2012 Korea University School of Law (J.D., summa cum laude)
2009 Korea Advanced Institute of Science and Technology (KAIST) (B.S.)

Selected Activities

Publications
COVID-19 and issues on financial contracts, BFL No. 103 (Co-author, Seoul National University Center for Financial Law, 2020)
Awards
IFLR 1000 - Leading Lawyer (2022-2024)
IFLR Asia-Pacific Awards - Rising Stars (2021)

Qualifications

2023 New York
2012 Korea

Awards and Recognition

Related Content

View more

Awards and Recognition